Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Kee Fong Loo"'
Autor:
Alan Wigg, Jonathan Tibballs, Richard Woodman, Katherine Stuart, Hien Le, Stuart K. Roberts, John K. Olynyk, Simone I. Strasser, Michael Wallace, Jarad Martin, Annette Haworth, Nicholas Hardcastle, Kee Fong Loo, Colin Tang, Yoo Young Lee, Julie Chu, Richard De Abreu Lourenco, Adam Koukourou, Diederick De Boo, Kate McLean, Jackie Buck, Rohit Sawhney, Amanda Nicoll, Anouk Dev, Marnie Wood, Alicia Braund, Martin Weltman, Richard Khor, Miriam Levy, Tim Wang, Michael Potter, James Haridy, Ashok Raj, Oliver Duncan, Amany Zekry, Natalie Collier, James O’Beirne, Catherine Holliday, Yuvnik Trada, Jaw Tronidjaja, Jacob George, David Pryor
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-9 (2024)
Abstract Background Therapeutic options for early-stage hepatocellular carcinoma (HCC) in individual patients can be limited by tumor and location, liver dysfunction and comorbidities. Many patients with early-stage HCC do not receive curative-intent
Externí odkaz:
https://doaj.org/article/6d523d1c82814f78b6224ff1b323717f
Autor:
Kee Fong Loo, Richard J Woodman, Damjana Bogatic, Vidyaleha Chandran, Kate Muller, Mohamed Asif Chinnaratha, John Bate, Kirsty Campbell, Matthew Maddison, Sumudu Narayana, Hien Le, David Pryor, Alan Wigg
Publikováno v:
JGH Open, Vol 6, Iss 9, Pp 599-606 (2022)
Abstract Background and Aim The rate of contraindications to percutaneous ablation (PA) for inoperable early hepatocellular carcinoma (HCC) and subsequent outcomes is not well described. We investigated the prevalence and outcomes of inoperable early
Externí odkaz:
https://doaj.org/article/acdd0fd29ae14e5f84caba52ec6c83b7
Autor:
Vidhyaleha Chandran, Arvinf Rajandran, Kee Fong Loo, John Bate, Alan Wigg, Mohamed A. Chinnaratha
Publikováno v:
Internal medicine journalReferences.
The epidemiology of chronic liver disease is changing with the introduction of potent antiviral therapies for chronic hepatitis C virus (HCV) and the increasing prevalence of non-alcoholic steatohepatitis (NASH).To establish the impact of this change
Autor:
Vidyaleha Chandran, Mohamed A. Chinnaratha, Richard W. Woodman, Hien Le, Damjana Bogatic, Kirsty Campbell, John Bate, Sumudu K. Narayana, David Pryor, Alan Wigg, Matthew Maddison, Kate Muller, Kee Fong Loo
Background & Aims:The rate of contraindications to percutaneous ablation (PA) for inoperable early HCC, and subsequent outcomes is not well described. We investigated the prevalence and outcomes of inoperable early HCC patients with contraindications
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fff0da68c714f47453079dfa9550431e
https://doi.org/10.21203/rs.3.rs-473644/v1
https://doi.org/10.21203/rs.3.rs-473644/v1
Autor:
Richard Khor, Rebekah Mott, Katherine A. Stuart, Hien Le, Trish Jenkins, Howard Liu, Ee Siang Choong, Shamira Cross, Julie Chu, Andrew Oar, David Pryor, Joanne Smart, Swetha Sridharan, Wei Wang, Alan Wigg, Kee Fong Loo, Yoo Young Lee, N. Anderson
Publikováno v:
Journal of medical imaging and radiation oncologyReferences. 65(3)
Introduction Stereotactic body radiotherapy (SBRT) is an emerging, therapeutic option in the management of hepatocellular carcinoma (HCC). A multicentre Liver Ablative Stereotactic Radiation (LASR) database was established to provide a collaborative